Biogen Idec Inc. Press Releases

Get BIIB Alerts
*Delayed - data as of Jul. 24, 2014  -  Find a broker to begin trading BIIB now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By

PLEGRIDY™ (Peginterferon beta-1a) Approved in the European Union for the Treatment of Multiple Sclerosis
7/23/2014 11:41:00 AM - Business Wire

Biogen Idec Second Quarter 2014 Revenues Increase 40% to $2.4 Billion; Company Raises Financial Guidance for the Year
7/23/2014 6:45:00 AM - Business Wire

Biogen Idec and Yahoo Health Spotlight Visionaries Whose Work Benefits People with Multiple Sclerosis (MS)
7/16/2014 8:00:00 AM - Business Wire

Biotech Equities under the Scanner -- Research on Alexion Pharma, InterMune, Cytokinetics, and Biogen Idec
7/7/2014 5:55:00 AM - PR Newswire

RBCC Developing New Tech to Help Prevent Deaths From Prescription Overdoses
7/2/2014 5:00:00 AM - Business Wire

Biogen Idec to Report Second Quarter 2014 Financial Results on July 23, 2014
6/30/2014 4:01:00 PM - Business Wire

Biogen Idec and AbbVie Announce Positive Top-Line Results from Phase 3 Study Investigating Daclizumab High-Yield Process in Multiple Sclerosis
6/16/2014 7:30:00 AM - Business Wire

RBCC to Expand Market for 'Underused' Addiction Treatment With New Technology
6/11/2014 5:00:00 AM - Business Wire

FDA Approves Biogen Idec’s ELOCTATE™, First Hemophilia A Therapy to Extend the Interval between Prophylactic Infusions, for Both Adults and Children
6/6/2014 4:55:00 PM - Business Wire

Technical Snapshot on Biotech Stocks -- Research on Aegerion Pharma, Biogen Idec, Lexicon Pharma, and Curis
6/5/2014 8:30:00 AM - PR Newswire

Alexandria Real Estate Equities, Inc. Receives LEED Gold Certification for Biogen Idec Inc.'s Build-to-Suit Headquarters in Cambridge, Massachusetts
6/2/2014 8:30:00 AM - PR Newswire

Data from Biogen Idec’s Portfolio of Multiple Sclerosis Therapies and Pipeline Featured at Medical Congresses
5/30/2014 7:30:00 AM - Business Wire

RBCC 3D Bioprinting Partner Awarded Prestigious Grant for Microgravity Research
5/29/2014 5:00:00 AM - Business Wire

Biogen Idec 2014 Annual Shareholder Meeting Webcast
5/28/2014 4:01:00 PM - Business Wire

Array BioPharma Announces Drug Discovery Collaboration Agreement With Biogen Idec
5/28/2014 9:00:00 AM - PR Newswire

Biogen Idec Announces Official Partnership with Sailing Sclerosis’ “Oceans of Hope” to Globally Change Perceptions of MS
5/28/2014 2:00:00 AM - Business Wire

CHMP Adopts Positive Opinion for PLEGRIDY™ (Peginterferon Beta-1a) as a Treatment for Multiple Sclerosis in the European Union
5/23/2014 7:59:00 AM - Business Wire

RBCC and n3D Take World’s First Commercially Available 3D Bioprinting System Global
5/22/2014 5:00:00 AM - Business Wire

Biogen Idec to Present at the Sanford Bernstein 30th Annual Strategic Decisions Conference
5/21/2014 4:01:00 PM - Business Wire

Semi-Annual Changes to the NASDAQ OMX CRD Global Sustainability Index
5/19/2014 8:05:00 AM - GlobeNewswire

Technical Coverage on Biotech Stocks -- Research on Athersys, Lexicon Pharma, Biogen Idec, and Theravance
5/12/2014 12:30:00 PM - PR Newswire

Richard A. Rudick Joins Biogen Idec as Vice President, Development Sciences, Value-Based Medicine
5/12/2014 7:00:00 AM - Business Wire

Biogen Idec and Sobi to Donate 1 Billion International Units of Clotting Factor to Support Treatment of Hemophilia in Developing World
5/12/2014 2:00:00 AM - Business Wire

Biogen Idec to Present at the Bank of America Merrill Lynch 2014 Health Care Conference
5/8/2014 4:01:00 PM - Business Wire

New TYSABRI® Analysis at AAN Annual Meeting Shows Improved Walking Speed in Significant Number of MS Patients
5/1/2014 7:30:00 AM - Business Wire